Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Nelson

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Factors Underlying Patient and Surgeon Willingness to Participate in a Placebo Surgery Controlled trial: A Qualitative InvestigationSamantha Bunzli, Elizabeth Nelson, Laura Wall, et al.
BMC Public Health|February 9, 2024
Study protocol of a randomized controlled trial to assess the efficacy of the "PrEPare for Work" intervention to enhance PrEP uptake and optimize adherence for HIV prevention among male sex workers in the U.SKatie B Biello, Philip A Chan, Colleen D Ndoye, et al.
The Oncologist|June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid TumorsBlessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
The Bone & Joint Journal|November 30, 2024
Willingness to participate in placebo-controlled surgical trials of the kneeLaura Wall, Samantha Bunzli, Elizabeth Nelson, et al.
Annals of Surgery|December 22, 2020
Placebo Surgery Controlled Trials: Do They Achieve What They Set Out To Do? A Systematic ReviewSamantha Bunzli, Emma Choong, Cade Shadbolt, et al.
International Journal of Hygiene and Environmental Health|September 13, 2024
Long-term nighttime aircraft noise exposure and risk of hypertension in a prospective cohort of female nursesJunenette L Peters, Stephanie T Grady, Francine Laden, et al.
Journal of Hematology|July 15, 2022
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series ExperienceBlessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, et al.
Molecular Cancer|March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE studyBlessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
NPJ Precision Oncology|February 21, 2023
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) studyBlessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
Leukemia|March 11, 2023
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP studyKate Manos, Geoffrey Chong, Colm Keane, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Factors Underlying Patient and Surgeon Willingness to Participate in a Placebo Surgery Controlled trial: A Qualitative InvestigationSamantha Bunzli, Elizabeth Nelson, Laura Wall, et al.
BMC Public Health|February 9, 2024
Study protocol of a randomized controlled trial to assess the efficacy of the "PrEPare for Work" intervention to enhance PrEP uptake and optimize adherence for HIV prevention among male sex workers in the U.SKatie B Biello, Philip A Chan, Colleen D Ndoye, et al.
The Oncologist|June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid TumorsBlessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
The Bone & Joint Journal|November 30, 2024
Willingness to participate in placebo-controlled surgical trials of the kneeLaura Wall, Samantha Bunzli, Elizabeth Nelson, et al.
Annals of Surgery|December 22, 2020
Placebo Surgery Controlled Trials: Do They Achieve What They Set Out To Do? A Systematic ReviewSamantha Bunzli, Emma Choong, Cade Shadbolt, et al.
International Journal of Hygiene and Environmental Health|September 13, 2024
Long-term nighttime aircraft noise exposure and risk of hypertension in a prospective cohort of female nursesJunenette L Peters, Stephanie T Grady, Francine Laden, et al.
Journal of Hematology|July 15, 2022
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series ExperienceBlessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, et al.
Molecular Cancer|March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE studyBlessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
NPJ Precision Oncology|February 21, 2023
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) studyBlessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
Leukemia|March 11, 2023
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP studyKate Manos, Geoffrey Chong, Colm Keane, et al.
Pageof 7